Previous Article | Next Article ![]()
Journal of Virology, October 2009, p. 10527-10537, Vol. 83, No. 20
0022-538X/09/$08.00+0 doi:10.1128/JVI.01235-09
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Marion Sourisseau,
Virginie Perrin,
Olivier Schwartz,
* and
Fabrizio Mammano
*
Institut Pasteur, Virus and Immunity Unit, CNRS URA 3015, 25-28 rue du Dr. Roux, 75724 Paris, France
Received 15 June 2009/ Accepted 31 July 2009
Type I interferons (IFN) inhibit several steps of the human immunodeficiency virus type 1 (HIV) replication cycle. Some HIV proteins, like Vif and Vpu, directly counteract IFN-induced restriction factors. Other mechanisms are expected to modulate the extent of IFN inhibition. Here, we studied the impact of IFN on various aspects of HIV replication in primary T lymphocytes. We confirm the potent effect of IFN on Gag p24 production in supernatants. Interestingly, IFN had a more limited effect on HIV spread, measured as the appearance of Gag-expressing cells. Primary isolates displayed similar differences in the inhibition of p24 release and virus spread. Virus emergence was the consequence of suboptimal inhibition of HIV replication and was not due to the selection of resistant variants. Cell-to-cell HIV transfer, a potent means of virus replication, was less sensitive to IFN than infection by cell-free virions. These results suggest that IFN are less active in cell cultures than initially thought. They help explain the incomplete protection by naturally secreted IFN during HIV infection and the unsatisfactory outcome of IFN treatment in HIV-infected patients.
Published ahead of print on 12 August 2009.
D.V. and M.S contributed equally as first authors.
O.S. and F.M. contributed equally as senior authors.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»